Rory L. Smoot

Also affiliated with Mayo Clinic in Arizona, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 22 papers. Top paper: “Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening”.

Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0872

N/A

0.581DataRank · unranked

47 citations

David Requena, Lavoisier Ramos‐Espiritu, Denise Ng, Patrick Bhola, Ype P. de Jong +31 more

Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the Liver

American Journal of Clinical Pathology(2020)10.1093/ajcp/aqaa115

N/A

0.538DataRank · unranked

35 citations

Mira Lotfalla, Thomas Czeczok, Taofic Mounajjed, Roger K. Moreira, Daniela Allende +11 more

Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma

Journal of Hepatology(2024)10.1016/j.jhep.2024.02.008

N/A

0.500DataRank · unranked

27 citations

Binbin Li, Jingchun Yang, Emilien Loeuillard, Hannah E. Stumpf, Hendrien Kuipers +11 more

Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometry

Communications Biology(2024)10.1038/s42003-024-06579-7

N/A

0.470DataRank · unranked

22 citations

Firdous Ahmad Bhat, Neha Joshi, Letícia Sandoval, Husheng Ding, Anu Jain +14 more

Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma

Annals of Surgical Oncology(2025)10.1245/s10434-025-18046-6

N/A

0.447DataRank · unranked

11 citations

Vanja Podrascanin, Zhihao Li, Jonas Santol, Markus Ammann, Lionel A. Kankeu Fonkoua +7 more

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

Digestive Diseases and Sciences(2021)10.1007/s10620-021-07303-9

N/A

0.385DataRank · unranked

12 citations

Thomas DeLeon, James M. Bogenberger, Rish K. Pai, Heidi Kosiorek, Jun Yin +26 more

Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative Surveillance

Gastro Hep Advances(2022)10.1016/j.gastha.2022.07.004

N/A

0.292DataRank · unranked

6 citations

Jacob Lui, Ryan J. Lennon, Arjun Chatterjee, Rondell P. Graham, Lizhi Zhang +14 more

Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis

Annals of Surgical Oncology(2025)10.1245/s10434-025-17991-6

N/A

0.241DataRank · unranked

4 citations

Jonas Santol, Vanja Podrascanin, Zhihao Li, Markus Ammann, Lionel A. Kankeu Fonkoua +7 more

Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor role

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research(2025)10.1016/j.bbamcr.2025.120081

N/A

0.104DataRank · unranked

1 citations

Alejandro Lillo, Ayano Kabashima, Jack W. Sample, Danielle M. Carlson, Rondell P. Graham +3 more

YAP ‐ TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape

FEBS Open Bio(2024)10.1002/2211-5463.13901

N/A

0DataRank · unranked

5 citations

Ryan Watkins, Jennifer L. Tomlinson, Jennifer A. Yonkus, Amro M. Abdelrahman, Caitlin B. Conboy +9 more

Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma

JHEP Reports(2024)10.1016/j.jhepr.2024.101068

N/A

0DataRank · unranked

8 citations

Jennifer L. Tomlinson, Roberto Alva‐Ruiz, Lindsey A. Gregory, Seul Kee Byeon, Amro M. Abdelrahman +13 more

A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis

PNAS Nexus(2024)10.1093/pnasnexus/pgae096

N/A

0DataRank · unranked

4 citations

Ana M. Gamo, Seung Hyuk Choi, Manoj Kumar, EeeLN H. Buckarma, Chantal E. McCabe +25 more

Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failure

HepatoBiliary Surgery and Nutrition(2025)10.21037/hbsn-24-464

N/A

0DataRank · unranked

6 citations

Jan Philipp Jonas, David Pereyra, Jonas Santol, Hubert Hackl, Tamara Kalchbrenner +12 more

LCK and resistance to cytotoxic chemotherapy via activating an AXL-PEAK1 signaling axis in cholangiocarcinoma.

JCO Global Oncology(2023)10.1200/go.2023.9.supplement_1.27

N/A

0DataRank · unranked

0 citations

Dong‐Gi Mun, Mincheng Yu, Jennifer L. Tomlinson, Amro M. Abdelrahman, Danielle M. Carlson +6 more

Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy

Surgery(2020)10.1016/j.surg.2019.12.008

N/A

0DataRank · unranked

50 citations

Alexandra M. Moore, Lavanya Yohanathan, Tatsuo Hata, Mark J. Truty, Rory L. Smoot +12 more

Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2–Platelet‐Derived Growth Factor Receptor Beta–Yes‐Associated Protein Signaling Axis

Hepatology(2021)10.1002/hep.31817

N/A

0DataRank · unranked

21 citations

Nellie A. Campbell, Li He, Daniel R. O’Brien, Mark S. Singer, Hassan Lemjabbar‐Alaoui +6 more

Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

medRxiv(2021)10.1101/2021.11.01.21265773

N/A

0DataRank · unranked

0 citations

Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam Sonbol, Daniel H. Ahn +25 more

Preclinical evaluation of LCK as a novel therapeutic target in YAP-activated and FGFR2-altered cholangiocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.463

N/A

0DataRank · unranked

1 citations

Jennifer A. Yonkus, EeeLN H. Buckarma, Dong‐Gi Mun, Nathan W. Werneburg, Ryan Watkins +13 more

Transcriptomic landscapes of effective and failed liver regeneration in humans

JHEP Reports(2023)10.1016/j.jhepr.2023.100683

N/A

0DataRank · unranked

15 citations

Laura Brunnthaler, Chantal E. McCabe, David Pereyra, Jonas Santol, Jessica A. Steadman +13 more

Tyrosine phosphorylation of YAP‐1 in biliary epithelial cells mediates posthepatectomy liver regeneration and is affected by serotonin

Journal of Cellular Biochemistry(2023)10.1002/jcb.30398

N/A

0DataRank · unranked

3 citations

Laura Brunnthaler, Ryan Watkins, David Pereyra, Judith Stift, Michaela Finsterbusch +5 more

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

Journal of Clinical Investigation(2020)10.1172/jci137110

N/A

0DataRank · unranked

399 citations

Jingchun Yang, EeeLN H. Buckarma, Juan Wang, Yuanhang Liu, Caitlin B. Conboy +9 more

Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma

Cellular and Molecular Gastroenterology and Hepatology(2024)10.1016/j.jcmgh.2024.01.006

N/A

0DataRank · unranked

15 citations

Binbin Li, Hannah E. Stumpf, Jingchun Yang, Jessica Willhite, Jennifer L. Tomlinson +7 more